Arrangement and Architecture of Tumor-Infiltrating Lymphocyte on H&E Slides Predict OS in Nivolumab Treated Non-Small Cell Lung Cancer

被引：1
|
作者：
Wang, X. [1 ]
Barrera, C. [1 ]
Bera, K. [1 ]
Lu, C. [1 ]
Feldman, M. [1 ]
Schalper, K. [2 ]
Rimm, D. [2 ]
Velcheti, V. [3 ]
Madabhushi, A. [1 ]
机构：
[1] Case Western Reserve Univ, Cleveland, OH 44106 USA
[2] Yale Univ, Sch Med, Pathol, New Haven, CT USA
[3] NYU Langone, Perlmutter Canc Ctr, New York, NY USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2019年 / 14卷 / 10期
关键词：
predictive image signatures; TILs; response to immunotherapy;
D O I：
10.1016/j.jtho.2019.08.710
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
MA25.02
引用
收藏
页码：S350 / S351
页数：2
相关论文
共 10 条
  • [1] Evaluation of tumor-infiltrating lymphocytes using routine H&E slides predicts patient survival in resected non-small cell lung cancer
    Rakaee, Mehrdad
    Kilvaer, Thomas K.
    Dalen, Stig Manfred
    Richardsen, Elin
    Paulsen, Erna-Elise
    Hald, Sigurd M.
    Al-Saad, Samer
    Andersen, Sigve
    Donnem, Tom
    Bremnes, Roy M.
    Busund, Lill-Tove
    HUMAN PATHOLOGY, 2018, 79 : 188 - 198
  • [2] Clinical significance of tumor-infiltrating lymphocytes investigated using routine H&E slides in small cell lung cancer
    Zhou, Guangrun
    Zheng, Jifang
    Chen, Zhiwei
    Hu, Dan
    Li, Suyu
    Zhuang, Wu
    He, Zhiyong
    Lin, Gen
    Wu, Biao
    Zhang, Wei
    Fang, Weimin
    Zheng, Fei
    Wang, Jiezhong
    Chen, Gang
    Chen, Mingqiu
    RADIATION ONCOLOGY, 2022, 17 (01)
  • [3] The Role of Tumor-Infiltrating Lymphocytes in Development, Progression, and Prognosis of Non-Small Cell Lung Cancer
    Bremnes, Roy M.
    Busund, Lill-Tove
    Kilvaer, Thomas L.
    Andersen, Sigve
    Richardsen, Elin
    Paulsen, Erna Elise
    Hald, Sigurd
    Khanehkenari, Mehrdad Rakaee
    Cooper, Wendy A.
    Kao, Steven C.
    Donnem, Tom
    JOURNAL OF THORACIC ONCOLOGY, 2016, 11 (06) : 789 - 800
  • [4] MANUFACTURE IMPROVEMENTS FOR TUMOR-INFILTRATING LYMPHOCYTES FROM HUMAN NON-SMALL CELL LUNG CANCER
    Zhou, Y.
    Noldner, P.
    Parrott, R. E.
    Antonia, S.
    Shaz, B.
    CYTOTHERAPY, 2023, 25 (06) : S209 - S210
  • [5] Prognostic impact of tumor-infiltrating lymphocytes in non-small cell lung carcinomas
    Mlika, Mona
    Saidi, Ayoub
    Mejri, Nesrine
    Abdennadher, Mehdi
    Haddouchi, Chokri
    Labidi, Soumeya
    Khiari, Hyem
    Boussen, Hamouda
    Hsairi, Mohamed
    Mezni, Faouzi
    ASIAN CARDIOVASCULAR & THORACIC ANNALS, 2022, 30 (02) : 177 - 184
  • [6] Distribution and Clinical Significance of IL-17A in Tumor-Infiltrating Lymphocytes of Non-Small Cell Lung Cancer Patients
    Xu, Rui
    Ke, Xing
    Shang, Wenwen
    Liu, Shuna
    Fu, Xin
    Wang, Ting
    Jin, Shuxian
    PATHOLOGY & ONCOLOGY RESEARCH, 2022, 28
  • [7] Impact of PD-L1 and PD-1 Expression on the Prognostic Significance of CD8+ Tumor-Infiltrating Lymphocytes in Non-Small Cell Lung Cancer
    Munari, Enrico
    Marconi, Marcella
    Querzoli, Giulia
    Lunardi, Gianluigi
    Bertoglio, Pietro
    Ciompi, Francesco
    Tosadori, Alice
    Eccher, Albino
    Tumino, Nicola
    Quatrini, Linda
    Vacca, Paola
    Rossi, Giulio
    Cavazza, Alberto
    Martignoni, Guido
    Brunelli, Matteo
    Netto, George J.
    Moretta, Lorenzo
    Zamboni, Giuseppe
    Bogina, Giuseppe
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [8] PD-1 expression in tumor infiltrating lymphocytes as a prognostic marker in early-stage non-small cell lung cancer
    Dan, Asaf
    Aricak, Ozan
    Rounis, Konstantinos
    Montero-Fernandez, M. Angeles
    Guijarro, Ricardo
    Ekman, Simon
    Ortiz-Villalon, Cristian
    De Petris, Luigi
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [9] Prognostic value of PD-L1 expression on tumor cells combined with CD8+ TIL density in patients with locally advanced non-small cell lung cancer treated with concurrent chemoradiotherapy
    Kathrin Gennen
    Lukas Käsmann
    Julian Taugner
    Chukwuka Eze
    Monika Karin
    Olarn Roengvoraphoj
    Jens Neumann
    Amanda Tufman
    Michael Orth
    Simone Reu
    Claus Belka
    Farkhad Manapov
    Radiation Oncology, 15
  • [10] Prognostic value of PD-L1 expression on tumor cells combined with CD8+TIL density in patients with locally advanced non-small cell lung cancer treated with concurrent chemoradiotherapy
    Gennen, Kathrin
    Kaesmann, Lukas
    Taugner, Julian
    Eze, Chukwuka
    Karin, Monika
    Roengvoraphoj, Olarn
    Neumann, Jens
    Tufman, Amanda
    Orth, Michael
    Reu, Simone
    Belka, Claus
    Manapov, Farkhad
    RADIATION ONCOLOGY, 2020, 15 (01)
1